Nicole Miller, MD
Urology · Nashville, TNNPI 1669672606
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,703 of the $73,477 with a category attached, or 64.9%. Boston Scientific accounts for 85.9% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $21,941, 6.5 times the $3,386 reported in 2019. Among urology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 125 payments — averaging $587.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$63K
- KARL Storz Endoscopy-america$4K
- Novo Nordisk Health Care AG$4K
- Intuitive Surgical$1K
- C. R. Bard, Inc. & Subsidiaries$822
- Supernus Pharmaceuticals, Inc.$375
- plus $368 from 4 others
What the payments were for
- Consulting fees$47,70365%
- Speaking & faculty fees$14,82520%
- Grants$1,5002%
- Travel & lodging$6,3139%
- Food & beverage$3,0704%
- Education$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 88 | $63,083 |
| KARL Storz Endoscopy-america | 7 | $4,176 |
| Novo Nordisk Health Care AG | 3 | $3,603 |
| Intuitive Surgical | 2 | $1,050 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $822 |
| Supernus Pharmaceuticals, Inc. | 16 | $375 |
| Richard Wolf Medical Instruments Corp. | 1 | $168 |
| Dendreon Pharmaceuticals LLC | 1 | $81 |
| Merck | 1 | $75 |
| Astellas Pharma US Inc | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL KIDNEY STONE DISEASE$34,545
- GENERAL - THERAPIES$4,459
- Lumenis Pulse 120H$3,191
- SCOPESAFELASER FIBER$1,438
- NEPHROSCOPE MIP M$1,373
- Da Vinci Surgical System$1,050
- GENERAL BPH$1,006
- Flex-X$863
- Moses 550 D\F\L$500
- LithoVue$384
- TRADE - 11278VSU FLEXC F/ACMI-OLYMPUS$316
- CYSTOSCOPE-URETHROSCOPE SHEATH ONLY,22FR$104
How this compares
$73,477 in reported general payments places this provider in the 90th percentile of 276 urology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Thiola EcTiopronin | 12 | $95,419 |
| MyrbetriqMirabegron | 25 | $15,094 |
| GemtesaVibegron | 19 | $10,640 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,246 |
| Tamsulosin Hcl | 50 | $588 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $92 |
| Indapamide | 19 | $90 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $45 | $15,09425 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 276 urology providers in Tennessee.
Other urology in Nashville
- L KnollNashville$2.1M
- Gautam JayramNashville$1M
- Roger DmochowskiNashville$763K
- Ashley TapscottNashville$425K
- Raoul ConcepcionNashville$339K
- Melissa KaufmanNashville$312K
- Sam ChangNashville$198K
- Benjamin DehnerNashville$165K
- Smita deNashville$100K
- Kelvin MosesNashville$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.